Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cardinal Health (NY: CAH )

127.03 +2.32 (+1.86%)
Official Closing Price Updated: 7:00 PM EST, Jan 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Cardinal Health

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
McKesson Stock Strength Rating Jumps To 81; Strong Start To '23
McKesson stock shows rising price performance earning it an upgrade to its IBD Relative Strength Rating, from 73 to 81. 
Via Investor's Business Daily
5 S&P 500 Stocks Showing Strength As Recession Fears Rise
Medical stocks are holding up amid economic and market uncertainty. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
This Dividend-Focused ETF Is Not a Good Dividend Investment
Invesco Dividend Achievers ETF buys companies that reliably increase their dividends, which is also why it's not a great dividend investment. 
Via The Motley Fool
The Latest Analyst Ratings for Cardinal Health
Via Benzinga
Cardinal Health's Earnings Outlook
Via Benzinga
7 Analysts Have This to Say About Cardinal Health
Via Benzinga
The Latest Analyst Ratings for Cardinal Health
Via Benzinga
Is It Too Late to Buy McKesson Stock?
The healthcare supplier has seen its shares climb 15% over the past year. 
Via The Motley Fool
Don't Wait for Your Dividends. Here's How You Can Collect Cash Every Month.
These stocks all pay more than what you'd get with the average stock on the S&P 500. 
Via The Motley Fool
3 Inflation-Resistant Businesses That Recently Raised Guidance
These stocks can be relatively safe places to invest in if you're worried about inflation. 
Via The Motley Fool
7 Stocks Set to Soar When the Market Recovers
Daring contrarians can bid up the danger with these intriguing market ideas. 
Via InvestorPlace
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company? 
Via News Direct
Is Market Sentiment Getting Behind This Emerging Small-Cap Specialty Syringe Medical Device Company?
The medical device and supply manufacturing industry is focused on the design and production of medical instruments and devices. 
Via Benzinga
This Stock Could Fill Your Pockets for Years to Come
$273 billion in sales from a company you've probably never heard of. 
Via The Motley Fool
3 Great Value Stocks To Buy Now For Steady Long-Term Growth
We explore three highly-ranked value stocks with resilient businesses—CAH, GPK and BJ—that investors might want to consider buying amid lingering inflation. 
Via Talk Markets
Is This Warren Buffett Stock a Buy for Dividend Growth Investors?
This Buffett-backed business leads the medical distribution industry. 
Via The Motley Fool
With COVID-19 Having Placed A Sharp Focus On Syringes, This Innovator Looks Back At A Year Of Successes Since Their 2022 IPO
Medical device company Sharps Technology Inc. (NASDAQ: STSS) is taking stock as it approaches one year since its initial public offering (IPO). Since its IPO, the company has taken major strides in... 
Via Benzinga
Battleground Stocks: 3 Heavily Shorted Meme Stocks to Watch
Heavily shorted meme stocks are often considered high-risk investments due to their volatility and potential for rapid gains or losses. 
Via InvestorPlace
Palantir Q4 Earnings Preview: Will The Data Software Company Deliver On CEO Expectations For A 'Strong Finish To The Year'?
Palantir Technologies Inc (NYSE: PLTR) is set to report fourth-quarter earnings results after the bell. The stock is up approximately 18% since the start of the year, but it's still down more than 40%... 
Via Benzinga
Why Palantir, Twilio, and HubSpot Each Surged Over 20% in January
Beaten-down enterprise software stocks got a relief rally in January. But will the good times last? 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023
Via Benzinga
Nasdaq Futures Fly As Meta Keeps Tech Earnings' Buoyancy Intact: Will Apple, Amazon, Alphabet Toe In Line?
The index futures point to a mixed opening on Thursday, as tech earnings continue to be encouraging. 
Via Benzinga
Can Market Sustain Upward Momentum In Tech-Heavy Earnings Week? Apple, Amazon, AMD, Alphabet, Ford Among Key Quarterly Reports To Watch
With a full week of earnings behind us, it’s time to take stock of the fourth-quarter reporting season so far. Overall, the news flow has been mixed, although tech earnings have grossly disappointed. 
Via Benzinga
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products 
Via News Direct
Topics Economy
Exposures Supply Chain
Sharps Technology Is Commercializing The Future Of Specialty Syringe Systems For The Healthcare Industry Through Its Next-Gen Polymer-Based Products
Sharps Technology, Inc. (NASDAQ: STSS) recently announced that the Company will be commercializing cutting-edge prefillable syringe system products to provide new solutions to customers in the... 
Via Benzinga
Sharps Technology Is Injecting A Better Solution Into The Healthcare Syringe Industry
Medical device company Sharps Technology, Inc. (NASDAQ: STSS) is closing out a successful year after its April initial public offering (IPO) on the NASDAQ market. The company focuses on the development... 
Via Benzinga
Buying These 2 Stocks Is a Good Way to Hedge Against a Market Crash
If the tide runs out, you won't be caught swimming naked with these two stocks in your portfolio. 
Via The Motley Fool
2 Dividend Aristocrat Stocks To Buy And Never Sell
A dividend aristocrat is a stock that is a member of the S&P500 that has raised dividend payments for at least 25 consecutive years. This filter alone is an effective way to identify companies with... 
Via Talk Markets
5 Stocks In S&P 500 ETF With 40% Gains In 2022
Despite the decline, some of the stocks in SPY’s portfolio have risen more than 40%. 
Via Talk Markets
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.